enVVeno Medical

enVVeno Medical

Health Care Equipment & Supplies
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

$4.3M

Market Cap • 11/13/2026

1999

(27 years)

Founded

2018

(8 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,3

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

24,3

EPS

—

Market Cap

Market Cap

4,3M

EV

-13,8M

EV/Revenue

0

EV/EBITDA

0,8

EV/EBIT

0,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-25,5%

Total Yield

-25,5%

Payout

0%

Retained Earnings

-183,1M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

2,2%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

6,3%

CAGR Net Income 5Y

5,5%

CAGR EPS 5Y

-29,6%

CAGR OCF 5Y

3,4%

Leverage

N.D./EBITDA

1,1

Debt/Equity

0%

Current Ratio

7,3

Quick Ratio

7,1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium